TABLE 1.
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Mean ± SD | ||
---|---|---|---|---|---|---|---|
2 weeks | Control | 15% | 24% | 6% | ‐1% | 5% | 10 ± 9% |
EGF | 29% | 37% | 16% | 17% | 49% | 30 ± 12% | |
4 weeks | Control | 22% | 9% | 4% | 24% | 30% | 18 ± 10% |
EGF | 47% | 44% | 23% | 30% | 48% | 38 ± 10% | |
8 weeks | Control | 18% | 19% | 15% | 13% | 41% | 21 ± 10% |
EGF | 48% | 38% | 23% | 41% | 69% | 44 ± 15% |
Human cortical ovarian pieces were collected from five patients who had PCOS. The tissues were cut into small cubes and incubated with or without EGF for 30 minutes. After being xenografted into the kidney capsule of ovariectomized SCID mice, the follicular distributions in different groups were quantified at 2, 4, and 8 weeks of in vivo development. To statistic the change of follicle activating proportions, each data from individual patient was normalized by the original activating ratio in this patient from fresh tissue before transplantation. Data represent the mean ± SD of biological triplicate experiments.